This study demonstrates that microinjection of an AMPA/kainate glutamate antagonist elicits motivated fear and feeding behaviour mapped along rostrocaudal gradients of positive-to-negative valence in nucleus accumbens shell (similar to rostrocaudal shell gradients recently reported for GABA agonist microinjections). Rats received rostral or caudal microinjections of the glutamate AMPA/ kainate receptor antagonist DNQX (0, 50, 450 or 850 ng in 0.5 mL) or the NMDA receptor antagonist MK-801 (0, 0.5, 1 or 2 mg in 0.5 mL), into medial accumbens shell prior to behavioural tests for fear, feeding or conditioning of place preference or avoidance. Another group received rostral or caudal microinjections of DNQX in nucleus accumbens core. Rostral shell DNQX microinjections potently increased appetitive food intake and established only weak conditioned place avoidance. Caudal shell DNQX microinjections elicited defensive treading behaviour, caused rats to defensively bite the experimenter and emit fearful distress vocalizations when handled, and established strong conditioned place avoidance. By contrast, no rostrocaudal gradients of motivational bivalence were produced by microinjections of the glutamate AMPA/kainate receptor antagonist DNQX into the core, or by microinjections of the NMDA antagonist MK-801 into the shell. Our results indicate that appetitive and aversive motivation is carried in anatomically differentiated channels by mesocorticolimbic glutamate signals to microcircuits in the medial shell. Hyperpolarization of local shell ensembles by AMPA/kainate glutamate receptor blockade elicits fear and feeding behaviours mapped along distinct positive-to-negative rostrocaudal gradients.
Introduction
The nucleus accumbens mediates both positive motivation (appetitive behaviour and reward) and negative motivation (aversive behaviour and stress) (Blackburn et al., 1992; Salamone, 1994; Wise, 1998; Berridge et al., 1999; Gray et al., 1999; Kelley, 1999; Koob, 1999; McBride et al., 1999; Horvitz, 2000) . An important topic for affective neuroscience is how neural mechanisms within accumbens channel the motivational valence of appetitive vs. aversive states.
Recent ®ndings suggest that accumbens GABAergic microcircuits may map appetitive and aversive channels of information along rostrocaudal gradients in the medial shell. Rostral microinjections of a GABA A agonist in the shell elicit appetitive eating behaviour, increase hedonic reactions to sweet tastes, and establish conditioned place preferences Basso & Kelley, 1999; Reynolds & Berridge, 2001 , 2002 . However, caudal shell muscimol microinjections produce defensive treading behaviour (Reynolds & Berridge, 2001 , 2002 , which is a natural species-speci®c fearful or antipredator response which rodents display towards rattlesnakes and scorpions (Owings & Coss, 1977; Wilkie et al., 1979; Londei et al., 1998; Owings & Morton, 1998) . Caudal shell GABAergic microinjections also elicit other aversive behaviours such as distress vocalizations, increase bitter-typical`disliking' reactions to tastes, cause conditioned place avoidances, and suppress food intake (Reynolds & Berridge, 2001 , 2002 .
Because the majority of GABA released within the accumbens comes from intrinsic medium spiny neurons projecting onto their neighbours (Sun & Cassell, 1993; Churchill & Kalivas, 1994; Kawaguchi et al., 1995; Van Bockstaele & Pickel, 1995; Meredith, 1999) , effects of GABA agonists there may reveal mainly how intrinsic microcircuits within the accumbens organize appetitive vs. defensive behaviour. Conversely, glutamate afferents convey extrinsic signals to the accumbens about motivational stimuli from prefrontal cortex, amygdala and hippocampus (Beckstead, 1979; Christie et al., 1987; Fuller et al., 1987; Sesack et al., 1989; McDonald, 1991; O'Donnell & Grace, 1993; Groenewegen et al., 1999; Everitt et al., 2001; Cardinal et al., 2002) . Glutamate acts on AMPA, kainate and NMDA receptors in accumbens, though it has been suggested that AMPA receptors are most exclusively postsynaptic in location and play a primary postsynaptic role in mediating amygdala and hippocampal inputs (Pennartz et al., 1990 (Pennartz et al., , 1991 1994; Meredith et al., 1993; O'Donnell & Grace, 1995; Hu & White, 1996; Gracy et al., 1997; Tarazi et al., 1998a, b) . Examining how glutamate transmission organizes appetitive and defensive behaviour within the accumbens shell may better reveal how the accumbens functions within larger mesocorticolimbic circuitry.
Suppression of glutamate neurotransmission by antagonist administration may hyperpolarize accumbens shell microcircuits similar to a GABA A agonist. Reduced glutamate levels in medial accumbens shell have been reported during both spontaneous appetitive eating behaviour and exposure to noxious stimuli (Saulskaya & Marsden, 1995 Rada et al., 1997; Saulskaya & Mikhailova, 2002) . In a related effect, AMPA/kainate receptor blockade in shell can speci®cally stimulate food intake (Maldonado-Irizarry et al., 1995; Stratford et al., 1998) .
If mesocorticolimbic glutamate inputs to the accumbens have partially segregated information channels for processing appetitive and aversive motivational signals, similar to GABA inputs, then glutamate antagonists may also elicit motivated behaviour of different valence along a similar rostrocaudal gradient as do GABA agonists (Reynolds & Berridge, 2001 , 2002 ). The present study tested this prediction. We compared eating behaviour and food intake vs. fearful defensive treading behaviour and assessed establishment of conditioned place avoidance after microinjections of DNQX, an AMPA/ kainate glutamate receptor antagonist, into the shell or core and after microinjections of MK-801, an NMDA receptor antagonist, into the shell. We found a rostrocaudal gradient of positive-to-negative motivational valence speci®cally after AMPA/kainate blockade in the shell.
Materials and methods
Experiment 1: fear and feeding behaviours elicited after AMPA/kainate or NMDA blockade in shell or core
In order to minimize the number of microinjections and associated site damage for each rat, Experiment 1 was divided into two comparisons using separate groups. An anatomical comparison group focused on the relative roles of shell vs. core, and a receptor subtype comparison group focused on the relative roles of glutamate AMPA/kainate vs. NMDA receptor subtypes. Because earlier studies and pilot core and shell data implicated the shell primarily for fear and feeding gradients, special emphasis was placed on the shell for the comparison of receptor subtypes.
The anatomical comparison assessed the fear and feeding effects of microinjections in either medial shell (60 rats) or accumbens core (21 rats) of the freshly prepared AMPA/kainate receptor antagonist DNQX (6,7-dinitroquinoxaline-2,3(1H,4H)-dione; Sigma, St Louis, USA; 0, 450, and 850 ng in 0.5 mL 50% DMSO : 50% 0.15 M sterile saline). The receptor subtype comparison assessed dose±response effects of shell microinjections of either the NMDA glutamate receptor antagonist MK-801 (dizocilpine; Sigma; 0, 0.5, 1.0, 2.0 mg in 0.5 mL 0.15 M sterile saline; 17 rats) or the AMPA/kainate glutamate receptor antagonist DNQX (0, 50, 450, and 850 ng in 0.5 mL; 30 rats). All studies were approved by the VCUCA committee of the University of Michigan in compliance with NIH standards.
Subjects
Male and female Sprague±Dawley rats (270±320 g at time of surgery) were group-housed (%21 8C; 12-h light : 12-h dark cycle) with ad libitum food (Purina rat chow) and water (tap water) available. Male and female data did not differ in initial analysis, and so are combined in results below.
Surgery
Rats were pretreated with 0.1 mL of atropine sulphate and anaesthetized with a mixture of ketamine HCl and xylazine (80 and 5 mg/kg, respectively) and placed in a sterotaxic apparatus (David Kopf; Tujunga, CA, USA) with the incisor bar set at 5.0 mm above interaural zero to avoid penetrating the lateral ventricles. Microinjection placements were staggered at 0.3-mm intervals in the anterior±posterior dimension within each group to cover the entire rostrocaudal extents of core and shell. Within other planes, cannula sites were clustered at 0.1-mm intervals or less along dorsoventral and mediolateral axes.
For both experimental groups, chronic microinjection guide cannulae (23-gauge) were implanted bilaterally 2.0 mm above accumbens sites either in the medial shell or in the core. Placement coordinates were chosen to ®t into the contours of the medial shell or into similar rostrocaudal levels of the core (Figs 1±3). Shell placements were AP 3.4±2.1 mm anterior to bregma, ML AE0.8±1.2 mm lateral to midline and DV 5.5 to 5.8 mm below the surface of the skull. This resulted in microinjections distributed across several rostrocaudal levels (all measurements anterior to bregma): %2.2 (n 2 rats), 1.7 (n 7), 1.6 (n 13), 1.2 (n 9), 1.0 (n 7), 0.7 (n 15) and 0.5 mm (n 5). Core placements were AP 3.4±2.6 mm anterior to bregma, ML AE1.4±2.6 mm lateral to midline, and DV 4.5±5.0 mm below the surface of the skull. Core microinjections were distributed across several rostrocaudal levels (all measurements anterior to bregma): %1.7 (n 1 rat), 1.6 (n 6), 1.2 (n 4), 1.0 (n 4) and 0.7 mm (n 6). Microinjection guide cannulae were anchored to the skull with screws and acrylic cement. A stainless steel obturator was inserted into each guide cannula to help prevent occlusions. Each rat received prophylactic penicillin (aquacillin; 45 000 U i.m.) after surgery. At least 7 days were allowed for recovery before the beginning of behavioural testing.
Intracerebral microinjections
While a rat was gently hand-held or cradled in the experimenter's arm, its bilateral cannulae were attached to a syringe pump via PE-20 tubing, and 0.5-mL microinjections were made at a rate of 0.30 mL/min using a stainless steel injector cannula (29-gauge) which extended 2.0 mm beyond the ventral tip of the cannula guide. Animals received doses of the antagonists or vehicle in counterbalanced order with 48-h rest between microinjection trials. Control microinjections contained only the appropriate vehicle for each drug. After infusions, the microinjectors remained in place for an additional 60 s to allow for drug diffusion before obturators were replaced, and the animal was placed immediately in the test chamber.
Behavioural eating and defensive treading tests
Rats had ad lib access to food and water prior to all tests. To assess the motivational valence of microinjection effects, rats were given simultaneous opportunities to express either eating, drinking or defensive treading behaviours as they chose during the 1-h test, and all behaviours were measured as described previously (Reynolds & Berridge, 2001) . Brie¯y, rats were habituated to test chambers for four consecutive days prior to microinjections and received a vehicle microinjection on the ®nal day of habituation. The transparent test chambers (23 Â 20 Â 45 cm) contained preweighed food (% 20 g Purina rat chow pellets), a water spout and wood shavings (2 cm deep) which could be used by a rat for defensive treading behaviour (and piled into mounds, usually positioned between the rat and its perceived threat such as the transparent front wall that revealed the experimenter). The behaviour of each rat was videotaped for later off-line analysis of durations of eating, drinking and defensive treading behaviour. Remaining food pellets were re-weighed after the 60-min test to measure grams eaten. The bedding and¯oor of the cage were also inspected for any food crumbs, which were separated and weighed (but this check never revealed more than a minimal dusting of crumbs, i.e. < 0.5 g).
Videoscoring of eating and defensive treading
The videotapes were scored by an experimenter who was blind to drug treatment. Behaviour was analysed for time spent in eating behaviour (scored whenever a rat's mouth touched a food pellet or showed continual rhythmic chewing movements), drinking behaviour (tongue in contact with the water spout) and defensive treading behaviour (alternating movements of both forepaws or of a single forepaw forward and backward, rapidly repeated and emitted in continuous bouts, and which shoved or sprayed wood shavings forward in front of the rat).
Defensive bites, distress calls and other fear behaviours
Defensive bites, distress calls and related fearful reactions to the experimenter were recorded at the end of each behavioural test session.
Using standardized movements, the experimenter quietly lifted the cage's lid, slowly reached into the test chamber (% 15 cm/s) with a latex-or cloth-gloved hand and, approaching from behind the rat, placed the palm of the hand over the rat's back (with ®ngers placed just below the rat's forearms to support its weight) to gently lift the rat up and slightly forwards out of the testing chamber. Rats sometimes responded defensively to the experimenter's approach and touch with bites, distress vocalizations and/or attempts to¯ee. These different defensive reactions were noted (each scored as either occurring or not), and the number of each type of reaction was also recorded in the NMDA vs. AMPA/kainate comparison group. A defensive bite was scored if the rat either actually bit the glove or attempted to bite by opening its jaw while suddenly moving its head toward the glove (as the experimenter's hand retreated). A distress vocalization was scored if the rat audibly vocalized within 1 s of being touched by the experimenter. An escape dash was scored if the rat suddenly dashed at least 20 cm away from the experimenter's hand or leapt over the chamber wall (>20 cm high). Occasionally, the rat reacted so defensively that it could not be taken out of the test chamber on the ®rst attempt (this happened only after caudal shell DNQX microinjections, as described below). In such cases, that animal was allowed to calm down for 1±30 min, depending on the duration of agitation displayed by the rat, and then another retrieval was attempted.
Histology
Rats were deeply anaesthetized with sodium pentobarbital after behavioural tests ended, given ink microinjections (0.5 mL) to aid anatomical localization of microinjection sites, and perfused transcardially with buffered saline followed by buffered 4% paraformaldehyde solution. The brains were removed, post®xed, coronally sectioned (40 mm), mounted on slides and stained with Cresyl Violet. Cannula placements were mapped onto corresponding coronal, saggital and horizontal atlas drawings of Paxinos & Watson (1997) .
Construction of functional maps
Criteria were set to plot the relative intensity of motivated behaviours elicited from neuroanatomical microinjection sites onto functional atlas maps (Reynolds & Berridge, 2001 , 2002 . For mapping purposes, the most effective DNQX dose was chosen on an individual basis to plot the maximal behaviour evoked from a site (450 or 850 ng). Symbols that expressed the maximal intensity of drug-elicited fear and feeding behaviours were plotted on digitized stereotaxic atlas maps using criteria below.
Eating behaviour
Intake criteria of >800, >400, >200, >100 and <100% (percentage increase in food intake after DNQX compared to vehicle) were used as the symbol levels to map maximal elicited eating behaviour at each site.
Defensive treading behaviour
Defensive treading criteria of >300, >200, >100, >50 and <50 s (time in seconds spent treading after DNQX minus time spent treading after vehicle) were used as symbol levels to map maximal defensive behaviour at each site.
Distress calls, bite attempts and related fear behaviours
Defensive bites, escape dashes and distress vocalizations elicited when the experimenter tried to pick up a rat at the end of a trial were mapped to re¯ect combined intensity. Bites appeared to be the most intense defensive reaction in the sense of having the highest threshold: bites occurred only in combination with distress vocalizations and escape dashes, whereas distress vocalizations or escape dashes could occur alone or together without bites. Incidence scores for each site were plotted using the criteria of triple combination of bite plus vocalization plus escape dash; double combination of vocalization plus dash; and single occurrence of either vocalization or dash.
Statistical analysis
Effects of each behaviour at rostrocaudal levels of shell or core were examined by one-factor (drug) repeated-measures or two-factor mixed within-or between-subjects ANOVA (drug Â anatomical levels of 2.2, 1.7, 1.6, 1.2, 1.0, 0.7 and 0.5 mm anterior to bregma). When signi®cant main effects were found, additional statistical analysis was performed with one-way ANOVA and post hoc comparisons with the Bonferroni test. Analysis of frequencies of distress vocalizations and biting behaviour were performed with w 2 and z-tests of proportions. Correlations were analysed with the Pearson Product Moment test.
Experiment 2: conditioned place preference or avoidance established by rostral vs. caudal shell glutamate blockade If a true motivational gradient exists for glutamatergic hyperpolarization of rostrocaudal microcircuits then a gradient should also be re¯ected in other types of motivated behaviour besides feeding and fear. Experiment 2 asked whether glutamate antagonist microinjections that produced a rostrocaudal gradient of feeding and fear in Experiment 1 would establish a rostrocaudal gradient of conditioned place preference or avoidance. The AMPA/kainate antagonist DNQX (450 ng) was chosen as the most effective drug and dose at producing a rostrocaudal feeding and fear gradient based on the results of Experiment 1.
Surgery
Twenty-eight male and female Sprague±Dawley rats were implanted with bilateral chronic indwelling cannulae in medial accumbens shell as in experiment 1 (rostral shell n 14, 2.2±1.2 mm; caudal shell n 14, 1.1±0.5 mm anterior to bregma).
Place conditioning training procedure
Conditioned place preference or avoidance was assessed via an unbiased preference conditioning procedure (Tzschentke, 1998) . We used a three-compartment apparatus, containing two large side chambers and a smaller central compartment (28 Â 21 Â 21-cm sides, 12 Â 21 Â 21-cm centre; Reynolds & Berridge, 2002) . The side compartments differed in wall colouring,¯oor texture and illumination levels. Initial tests prior to conditioning con®rmed that rats did not show signi®cant biases for either of the side chambers (n 8; F 1,15 3.65; P 0.10) (Tzschentke, 1998) , and a separate group of rats were used to con®rm that our conditioning procedures were effective at establishing preference for a place if paired with systemic diazepam (1 mg/kg, i.p.; n 6, F 1,11 5.98, P < 0.05) (Spyraki et al., 1985) .
Each rat was randomly assigned to have one side compartment paired with DNQX microinjection, and place assignments were counterbalanced across rats. To establish a conditioned place preference or avoidance, rats received four consecutive daily conditioning trials. On two trials, DNQX (450 ng in 0.5 mL; days 2 and 4) was paired with the assigned drug compartment for 10 min after microinjection, and on the other two trials vehicle was paired with the control compartment (days 1 and 3).
videotaped. Locations during test sessions were subsequently scored for cumulative seconds spent in each compartment (a rat was considered to be in a particular compartment whenever its head and both forelimbs were across the threshold).
Functional maps of conditioned place avoidance
To map place preference or avoidance, each rat's place score (measured in absolute seconds) was transformed into a percentage score by dividing the time it spent in its DNQX-paired chamber by the mean time all rats spent in that same chamber across all treatments. The result was expressed as a percentage score, which could be either positive (conditioned place preference) or negative (conditioned place avoidance). Place preference or avoidance percentage scores for each rat's sites were mapped onto a stereotaxic atlas using the criteria: >10% increase in place preference for the DNQX-paired place (compared to vehicle microinjection at the same site), no change in Fig. 1 . Saggital function maps of DNQX-elicited food intake and defensive treading behaviour (emitted during the 1-h test), and fearful defensive bites, vocalizations and escape dashes (elicited when the rat was retrieved after testing) for accumbens medial shell (0.9 mm lateral to midline) and core (1.9 mm lateral to midline; all cannula placements are plotted bilaterally, two sites for each rat). Rostrocaudal gradients for motivational valence and behavioural intensity were found for all behaviours. Food intake (left) was elicited most consistently and robustly from rostral shell regions, especially at 1.6 mm anterior to bregma. Defensive treading behaviour (middle) and distress calls, bites and related behaviour (right) were produced best from caudal shell regions, especially at 0.7 mm anterior to bregma. Core DNQX microinjections did not produce a rostrocaudal positive-to-negative gradient, although some rostral core injections sites also produced mild defensive treading. Stereotaxic atlas, Paxinos & Watson (1997). place preference or avoidance (<9% change), >10 or >25% increase in place avoidance.
Statistical analysis
Effects of DNQX microinjections on conditioned place preference were analysed by comparing durations (s) spent in each chamber using 2-way ANOVA (drug Â anatomical site), and signi®cant drug effects were further examined with Bonferroni post hoc tests.
Results
Experiment 1: AMPA/kainate blockade in shell (but not core) elicited rostrocaudal gradient of eating and defensive treading behaviours Shell-evoked eating behaviour: rostral advantage Clear and opposite rostrocaudal gradients were found in the shell for DNQX-elicited fear and feeding behaviours (Figs 1 and 2) . Food intake was increased most consistently and potently from rostral shell between 2.2 and 1.2 mm anterior to bregma, and the best sites were rostral to 1.5 mm (a level where the corpus callosum merges bilaterally and where the tenia tecta ends). In these rostral shell regions, DNQX at least doubled food intake in all rats except two (which were both still increased 93% above vehicle). Caudally in the shell (1.1±0.5 mm anterior to bregma), food intake was less consistently enhanced, and at least half of caudal shell sites failed to double food intake above vehicle levels.
Statistically, DNQX microinjections into the rostral half of the accumbens shell elicited signi®cantly more food intake than sites in the caudal half of the shell (ANOVA for site Â drug interaction, F 12,173 2.02, P < 0.05; Figs 1±4). Rats ate 300±400% more food pellets after DNQX than after vehicle at all rostral sites between 2.0 and 1.2 mm anterior to bregma (rostral %60% of shell; overall rostral shell F 2,89 43.42, P < 0.001), 1.7 mm anterior to bregma (F 2,20 21.84, P < 0.001), 1.6 mm (F 2,38 17.511, P < 0.001) and 1.2 mm (F 2,26 11.86, P < 0.001). Caudal shell sites caused less eating after DNQX, though still signi®cantly elevated food intake to 50±150% above vehicle levels (1.0 and 0.7 mm anterior to bregma, P < 0.05 each, but no signi®cant increase at 0.5 mm).
The largest increase in food intake was at %1.6 mm anterior to bregma in the rostral shell, where the 850-ng DNQX dose caused a 3.9 AE 0.49 g increase over vehicle in food intake, which was >5Â higher than that produced by the same dose more caudally at %0.7 mm (0.6 AE 0.48 g increase, P < 0.001; Fig. 4 ). In addition, increased intake (DNQX À vehicle intake) was positively correlated with degree of rostral placement in shell at both DNQX doses (450 ng, r 0.34, P < 0.01; 850 ng, r 0.41, P < 0.001). Drinking was typically low, and amount of water drunk was not altered by accumbens shell DNQX microinjections at any level.
Core-evoked eating behaviour: little to no gradient DNQX microinjections into the accumbens core hardly increased food intake, causing rats to eat food pellets only 50% above vehicle level on average (ANOVA for dose, F 2,59 5.62, P < 0.01). There was no rostrocaudal gradient in food intake after core DNQX microinjections (ANOVA for site Â dose interaction, F 6,59 1.86, not signi®cant; Figs 1±3 and 5). In fact, post hoc tests revealed that DNQX only increased food intake at the 450-ng dose (F 2,17 16.31, P < 0.05) and further only at one rostrocaudal level (% 1.6 mm). The higher DNQX dose, 850-ng, produced no effect on food intake at any level. Drinking behaviour was never altered after core DNQX microinjections.
DNQX-evoked defensive behaviour: caudal shell advantage
DNQX in the shell produced a caudally weighted gradient for defensive treading and other fearful behaviours (Figs 1 and 2 ). Defensive treading was maximal after DNQX between 1.1 and 0.5 mm anterior to bregma, and especially at 0.7-mm sites (a level where the nucleus of the horizontal limb diagonal band and lambdoid septal areas begin, and where the medial septal nuclei and nuclei of the vertical limb diagonal bands merge). Nearly all caudal shell sites produced at least 50 s of treading behaviour after DNQX and most caudal sites elicited at least 200 s of cumulative defensive treading behaviour (whereas vehicle microinjections elicited virtually none). Rostral shell sites usually elicited only small amounts of defensive treading and sometimes none. Over 25% of rostral sites elicited no defensive treading behaviour at all, and only one rostral shell rat out of 21 showed >200 s of treading.
Quantitative behavioural comparisons con®rmed that microinjections of DNQX at caudal sites elicited stronger defensive treading behaviour than at rostral sites (ANOVA for site Â drug interaction, F 12,173 2.70, P < 0.01; Figs 1±5) . Caudal shell DNQX microinjections robustly elicited up to 4 min cumulative defensive treading behaviour above vehicle levels at sites 1.0 mm (F 2,20 6.24, P < 0.02), 0.7 mm (F 2,44 14.73, P < 0.001), and 0.5 mm anterior to bregma (F 2,14 10.12, P < 0.01). Conversely, rostral shell DNQX injections at the same doses elicited only 1 min defensive treading at sites 2.2 mm (not signi®cant), 1.7 mm (F 2,20 3.50, P 0.064), 1.6 mm (F 2,38 7.08, P < 0.01) and 1.2 mm anterior to bregma (F 2,26 6.56, P < 0.01). The highest dose at caudal sites interacted to produce the greatest amounts of defensive treading behaviour (twoway ANOVA for dose Â site interaction, F 4,167 4.93, P 0.001; Fig.  4) . A correlation analysis of the relationship between rostrocaudal site and duration of defensive treading behaviour con®rmed that the glutamatergic enhancement of defensive treading behaviour (DNQX À vehicle) increased progressively as shell sites became more caudal (signi®cant at both doses: 450 ng, r 0.37, P < 0.005; 850 ng, r 0.45, P < 0.001).
Core-evoked defensive treading: weak reverse gradient DNQX microinjections into accumbens core elicited moderate defensive treading behaviour (ANOVA for dose F 2,59 10.21, P < 0.001) up to 2 min at the 850 ng dose, but only from rostral core sites at 1.2 mm anterior to bregma (F 2,11 6.43, P < 0.05; Figs 1±4 ) Inspection of the data suggested rostral core might support slightly more DNQXevoked defensive treading than caudal core (the opposite of the shell gradient), but this was a very weak trend and was not statistically signi®cant (ANOVA for dose Â site interaction) F 2,59 1.53, not signi®cant).
Shell-evoked fearful distress calls and bites: strong caudal shell fear gradient Over 90% of caudal shell DNQX sites produced defensive bites or attempts to bite the experimenter's hand at the end of the behavioural test, distress vocalizations and/or escape dashes. Only %50% of rostral sites produced any of these, and virtually no rostral sites produced defensive bites or bite attempts. Quantitative analysis con®rmed that distress calls, dashes and bites elicited at the end of the test session were evoked by shell DNQX microinjections (compared to vehicle; ANOVA for dose F 2,67 19. 03, P < 0.001) and most potently at caudal shell sites (ANOVA for site F 5,173 4.20, P < 0.01; Figs 1±4 ). Many rats which received DNQX microinjections at caudal shell sites between 1.0 and 0.5 mm anterior to bregma displayed all three fearful behaviours: (i) distress calls, (ii) escape dashes or successful leaps out of test chamber and (iii) bites (P < 0.05 each level). At rostral sites, DNQX evoked only one fear behaviour at a time (either distress calls or escape dashes), from only a few rats, and only at 1.6 mm anterior to bregma (P < 0.05; not at 2.2, 1.7 or 1.2 mm). A correlation analysis between these fearful behaviours and rostrocaudal site placement con®rmed that DNQX elicitation of defensive bites, distress calls and escape dashes was correlated with caudal placement: the more caudal the site, the greater the combined defensive reaction and greater the likelihood of bites (r 0.46, P < 0.001).
Core-evoked distress calls and bites: missing and no gradient
For accumbens core sites, by contrast, little to no defensive bites, distress vocalizations or escape attempts occurred when rats were retrieved after DNQX microinjections (ANOVA for dose F 2,59 2.82, Essentially no rostrocaudal gradient for eating or fear behaviour was found in the core when behavioural effects of accumbens core DNQX microinjections were anatomically mapped (Figs 1 and 2) . Few core sites elicited eating, and those few which did were not segregated rostrocaudally. The mapping of defensive treading sites con®rmed, if anything, a weak and reversed rostrocaudal gradient, with the few effective sites concentrated rostrally in accumbens core (1.7±1.2 mm anterior to bregma). The occasional defensive treading behaviour elicited at rostral core sites seems not likely to be due to diffusion of DNQX to the shell because these sites were closest to the rostral core which was relatively ineffective for eliciting treading, whereas caudal core sites which were ineffective were closest to caudal shell sites which produced the strongest defensive treading behaviour.
Overlap between appetitive and defensive shell sites
Many shell microinjection sites elicited both appetitive eating and defensive treading behaviour from the same rat successively during the same hour. Eating behaviour typically occurred ®rst, and was followed by a shift to defensive treading behaviour after 20±30 min. The relative intensities of fear and feeding behaviour conformed to the rostrocaudal gradients described above, but a considerable range of intermediate shell supported both fear and feeding behaviours. Approximately 40% of shell sites elicited at least some of both appetitive and defensive behaviours which exceeded mapping thresholds. However, strong behavioural extremes tended to be restricted to rostral or caudal ends of the shell. Sites of overlap between appetitive and defensive behaviours appeared to be evenly distributed throughout the shell between the rostrocaudal ends. When relative intensities of simultaneous fear and feeding behaviours were compared, a negative correlation was found between appetitive eating and defensive treading behaviour (450 ng, r À0.32, P < 0.02; 850 ng, r À0.21, P < 0.03), consistent with the rostrocaudal gradients described above. However, the joint appearance of both fear and feeding reactions after most middle shell DNQX microinjections led us to further examine their relative time course in the receptor subtype comparison below.
NMDA vs. AMPA/kainate receptor comparison: only DNQX (not MK 801) in shell elicited fear and feeding behaviours
For comparison of NMDA vs. AMPA/kainate receptor subtypes in eliciting fear and feeding behaviours from accumbens shell, we expanded the dose range to three doses of each antagonist plus vehicle (DNQX, 0, 50, 450 and 850 ng; MK-801, 0, 0.5, 1 and 2 mg). In addition, we assessed more sensitively the relative intensities of fear and feeding reactions during different time points within the 1-h test session, and further quanti®ed the number of defensive bites, distress vocalizations and escape dashes elicited when the experimenter retrieved a rat at the end of the session.
Eating behaviour: shell MK-801 decreased food intake and lacked gradient
Microinjections of MK-801 never increased food intake, at either rostral or caudal sites in the accumbens shell. Instead, shell MK-801 at the highest dose (2 mg) signi®cantly decreased eating behaviour (twoway ANOVA for drug F 3,65 3.64, P < 0.05; Table 1) at both rostral and caudal shell sites (site F 1,43 2.65, P 0.12). Only the highest dose (2 mg) of MK-801 suppressed food intake (F 3,34 3.77, P < 0.05), whereas 1-and 0.5-mg doses had no signi®cant effects.
By contrast, DNQX microinjections again increased food intake (F 3,106 29.68, P < 0.001), and rostral shell DNQX caused the greatest food intake (>500% increase), while caudal shell caused a lesser increase (% 300% increase; site F 1,106 6.28, P 0.02). The two highest doses, 450 and 850 ng, each increased eating more than the lowest dose (F 3,47 17.07, P < 0.001). The time course of eating behaviour showed an immediate and early effect of DNQX in the shell. Rostral shell DNQX increased time spent eating during the ®rst 5-min bin of the 1-h session (min 0±5, F 3,47 5.45, P < 0.005), and for every subsequent bin up to 20 min (min 5±20, P < 0.01 each), but not for later bins (min 21±60). Caudal shell DNQX increased eating only in the ®rst three 5-min bins (15 min after injection each P < 0.02), but not during any later time bins in the hour (Fig. 5 ).
Defensive treading: shell MK-801 caused mild defensive treading without gradient MK-801 microinjections caused mild defensive treading behaviour at all shell sites (F 3,64 11.66, P < 0.001; Table 1 ). All doses of MK-801 elicited between 50 and 80 s cumulative treading behaviour regardless of site or dose (rostral, F 3,30 5.24, P < 0.01; caudal, F 3,33 7.09, P < 0.01; site, F 1,64 1.47, P 0.24). The mild defensive treading elicited by MK-801 began by 5 min after microinjection and continued steadily to 60 min (P < 0.05 for 10 of 12 bins). By contrast, DNQX microinjections again elicited strong defensive treading behaviour along a rostrocaudal gradient (F 1,106 17.66, P < 0.001), with a signi®cant advantage for caudal microinjections over rostral microinjections (F 1,106 9.28, P 0.005). In the caudal shell, DNQX elicited more defensive treading than did MK-801 at the same sites (ANOVA for drug F 1,167 4.92, P < 0.03). The dose± response effect for DNQX was roughly linear in caudal shell (F 3,54 16.01, P < 0.001) and the highest dose of DNQX elicited more treading (>200 s cumulative) than the lowest dose (% 70 s; P < 0.001). Rostral DNQX elicited mild defensive treading behaviour (50±80 s; F 3,47 4.83, P < 0.01), but this reached signi®cance only for the middle dose (450 ng; P < 0.01). DNQX-elicited defensive treading behaviour was delayed and late, by contrast to its immediate and early effects on eating behaviour (Fig. 5) . No defensive treading enhancement was detectable in the ®rst 10 min of the test. DNQX-elicited defensive treading from the caudal shell began 10 min after microinjection (min 10±15, F 3,54 4.76, P < 0.01) and lasted until the end of the 60-min test (min 15±60, each 5-min bin P < 0.01). After rostral shell microinjections, defensive treading was even more delayed, not becoming evident until 30 min into the test (min 30±35, F 3,47 7.27, P < 0.001), when it then remained elevated over vehicle for the rest of the test (min 35±60, each 5-min bin P < 0.05).
Defensive bites and distress calls: no MK-801 fear behaviour or gradient MK-801 never caused defensive bites, distress vocalizations or escape dashes when the experimenter picked up the rat at the end of the test (ANOVA for dose F 1,64 0.45, P 0.70). However, DNQX microinjections again greatly increased all of these fear behaviours (F 1,106 9.53, P < 0.001). Caudal DNQX sites produced greater increases in defensive bites, vocalizations and dashes than did rostral shell sites (F 1,106 8.64, P < 0.04) (Fig. 6) . Caudal shell doses of 450 and 850 ng both increased combined defensive bites, distress vocalizations and escape dashes (P < 0.01 each), whereas only the highest dose, 850 ng, increased them at rostral sites (P < 0.05). This pattern of more enhanced fearfulness after caudal shell DNQX compared to rostral DNQX was con®rmed by incidence analysis of the percentage of rats which emitted each defensive reaction (w 2 , P < 0.03). For example, caudal 850 ng DNQX caused 93% of rats to display at least one of these fearful behaviours compared to only 50% of rats which received the same dose at rostral sites (P < 0.05). Even more striking, rostral animals only displayed at most a single distress vocalization or a single escape dash, and never emitted a defensive bite, whereas %40% of rats with caudal shell sites exhibited a double or triple combination of bites, escape dashes and distress vocalizations mixed together (and 22% tried to bite the experimenter; Fig. 6 ).
Experiment 2: place conditioning DNQX microinjections in shell established a rostrocaudal gradient of negative conditioned place avoidance (two-way ANOVA for dose F 1,47 75.69; P < 0.001; Figs 7 and 8 ). This univalent avoidance gradient was re¯ected in stronger conditioned place avoidance after caudal shell DNQX pairings than after rostral shell pairing (rostral, 25% mean avoidance; caudal, 55% mean avoidance; F 1,47 13.79, P < 0.001; Fig. 8 ). For caudal shell, 83% of sites caused strong avoidance (>25% avoidance) and no caudal site failed to cause at least 10% avoidance. For rostral shell, only 31% of sites met the criteria for strong avoidance and nearly a quarter of rostral sites caused no detectable avoidance at all (Fig. 8) . However, signi®cant place avoidances overall were established by DNQX at both accumbens shell sites compared to vehicle pairings (caudal sites F 1,23 69.61, P < 0.001; rostral sites F 1,23 31.89, P < 0.001). Several rats whose microinjection sites fell bilaterally outside accumbens shell in accumbens core, ventral pallidum or septum displayed no detectable conditioned place preference or avoidance after DNQX pairings (Fig. 8) . These negative sites agree with results from experiment 1, and overall negative sites for feeding, treading, biting and place conditioning were found just dorsal to the shell in the vertical band (n 6) and in the septum (n 3) and ventral pallidum (n 2).
Discussion
Blockade of AMPA/kainate glutamate receptors in the medial shell of nucleus accumbens caused appetitive eating behaviour, defensive treading behaviour, defensive bites and distress calls, all along rostrocaudal gradients of positive-to-negative motivational valence. DNQX microinjections in rostral shell (rostral to 1.1 mm anterior to bregma) most effectively increased food intake, as earlier reported by Kelley and colleagues (Maldonado-Irizarry et al., 1995; Stratford et al., 1998) . Conversely, DNQX microinjections in caudal shell (caudal to 1.1 mm anterior to bregma) most effectively elicited defensive treading behaviour during the same test, and caused fearful bites and distress calls to be elicited at the end of the test session when the rat was touched by the experimenter. These results support the hypothesis that glutamate signals to rostral vs. caudal microcircuits in medial shell may differentially carry appetitive vs. aversive channels of motivational information. AMPA/kainate receptors in the medial shell appear most crucial for generating a glutamatergic positive-to-negative rostrocaudal gradient in motivation. DNQX microinjection into medial shell produced feeding at rostral sites and defensive behaviour at caudal sites as described above. However, NMDA receptor blockade by MK-801 at similar shell sites only suppressed food intake and elicited mild defensive treading at all sites, with no hint of rostrocaudal gradient. In the accumbens core a reverse rostrocaudal gradient, if anything, characterized defensive treading after AMPA/kainate blockade. In the core, only weak treading occurred and only after rostral DNQX. Similarly, eating behaviour was elicited by DNQX in the core only sporadically, only slightly, and without rostrocaudal gradient. Thus we conclude that glutamate blockade produces rostrocaudal gradients of appetitive±aversive motivation in accumbens shell but not in accumbens core, and within the shell by blockade of AMPA/kainate receptors but not NMDA receptors.
Glutamate receptor subtype differences
Why does AMPA/kainate blockade but not NMDA blockade in shell produce rostrocaudal gradients of positive±negative motivational valence? One possibility is that behavioural fear and feeding differences between AMPA/kainate and NMDA antagonists may be due to the different anatomical distributions of these receptor subtypes on presynaptic or postsynaptic elements of accumbens neurons. Glutamate AMPA receptors in accumbens are located mainly on postsynaptic dendrites of medium spiny GABAergic neurons, whereas kainate and NMDA receptors have a relatively higher proportion located on presynaptic axon terminals from hippocampus and cortex, in addition to postsynaptic sites (Tarazi et al., 1998a, b) . In addition, it has been reported that DNQX and other AMPA antagonists suppress stimulation-induced excitatory postsynaptic potentials in accumbens more effectively than do NMDA antagonists (Pennartz et al., 1990 (Pennartz et al., , 1991 Hu & White, 1996) . Thus, DNQX microinjections which block postsynaptic AMPA receptors may have more effectively hyperpolarized local accumbens microcircuits by blocking excitatory inputs (Uchimura et al., 1989; Pennartz et al., 1990 Pennartz et al., , 1991 Hu & White, 1996; Crowder & Weiner, 2002) . The suggestion that postsynaptic hyperpolarization of local microcircuits in accumbens shell may be key to inducing rostrocaudal gradients of motivated feeding vs. fearful behaviours would be consistent with our previous demonstrations that GABA A agonist microinjections cause similar gradients of positive-tonegative motivational valence.
Another possible explanation for rostrocaudal gradients of bivalent motivation after blockade of AMPA/kainate receptors, but not NMDA receptors, is the different molecular organization and intracellular effects of these receptor subtypes. AMPA, kainate and NMDA receptors are composed of different molecular subunits, and there is some evidence that subunit composition can in¯uence receptor function (Malinow & Malenka, 2002; Mead & Stephens, 2003) . Finally, there is a possibility that dopamine, which itself modulates appetitive and defensive behaviour (Salamone, 1994; Berridge & Robinson, 1998; Horvitz, 2000; Koob & Le Moal, 2001; Salamone & Correa, 2002) , may also modulate glutamate-related rostrocaudal gradients of motivational valence, and may interact speci®cally with receptor subtypes (Hotsenpiller et al., 2001; Chao et al., 2002; Park et al., 2002; Ikeda et al., 2003) . Glutamate antagonists in accumbens not only increase food intake as shown here but also potently increase local dopamine levels during feeding behaviour (Taber & Fibiger, 1997) . Complex and reciprocal dopamine±glutamate interactions have been shown to modulate many types of motivational processes (Smith-Roe & Kelley, 2000; Vanderschuren & Kalivas, 2000; Cornish & Kalivas, 2001; Pulvirenti & Diana, 2001; Kiyatkin, 2002) , and deserve further investigation regarding rostrocaudal gradients of fear and feeding behaviours.
Accumbens core±shell differences
Only the shell of nucleus accumbens generated positive-to-negative rostrocaudal gradients of motivated behaviour after DNQX microinjections. The same microinjections in accumbens core caused only weak and sporadic behavioural effects (with a very slight rostral core advantage for both valences of feeding and fear, if any gradient at all). A unique role for accumbens shell in generating feeding and fear gradients is consistent with both behavioural work and neuroanatomical connections which suggest the shell may be more involved than the core in mediating motivational and emotional processes (Heimer et al., 1991; Zahm & Brog, 1992; Zahm & Heimer, 1993; Heimer et al., 1997; Everitt et al., 1999; Kelley, 1999; Cardinal et al., 2002) .
Perhaps the most important issue here is how local ensembles within the shell generate rostrocaudal gradients of positive±negative motivation. Why do rostral shell microinjections of DNQX or muscimol produce positive appetitive behaviours whereas caudal microinjections produce negative fearful behaviours? We can only note that the rostral shell differs from the caudal shell in both anatomical connections (Phillipson & Grif®ths, 1985; Wright et al., 1996; Gorelova & Yang, 1997; Totterdell & Meredith, 1997; Mulder et al., 1998; Groenewegen et al., 1999; Ding et al., 2001; French & Totterdell, 2002) and neurochemical composition (Zaborszky et al., 1985; Bardo & Hammer, 1991; Tribollet et al., 1992; Voorn & Docter, 1992; Berridge et al., 1997; Delfs et al., 1998) . It is not yet clear how neurobiological differences between rostral and caudal shell relate to its generation of rostrocaudal gradients of bivalent motivation. However, the various differences between rostral and caudal shell suggest that microcircuits in those regions may be differently embedded in larger mesocorticolimbic circuits involving ventral pallidum, cortex and other structures that mediate motivational and cognitive processing (Sarter & Bruno, 1997; Swanson, 2000; Turchi & Sarter, 2001; Neigh-McCandless et al., 2002) . Our results also suggest that there may be segregated channels of motivational valence signals within such larger brain circuits.
Comparison of glutamatergic and GABAergic gradients
The shell glutamate (DNQX) gradients described here are quite similar to the GABAergic rostrocaudal positive-to-negative gradients for eliciting feeding and fear behaviour we previously reported (Reynolds & Berridge, 2001 , 2002 . However, there are a few differences. For example, >40% of DNQX microinjections in medial shell elicited both feeding and fear behaviours in the same rat. In our earlier GABAergic studies <10% of muscimol microinjections elicited such ambivalent fear or feeding behaviours. Also, GABAergic microinjections produce a bivalent rostrocaudal gradient of conditioned place preference or avoidance which mirrors their feeding or fear gradient of elicited behaviour. By contrast, glutamatergic blockade here produced a univalent gradient of conditioned place avoidance which increased monotonically at caudal shell sites.
Several explanations might account for the greater ability of DNQX glutamatergic blockade to simultaneously elicit both appetitive and defensive behaviours, whereas GABA tended more to elicit only one motivational valence or the other. First, in the present study, DNQX was dissolved in a DMSO±saline vehicle which is more lipophilic than the saline used as vehicle for muscimol, and hence DNQX may have diffused to a larger extent. However, diffusion could not have been very great, because DNQX in the vertical limb of the diagonal band, septum or ventral pallidum adjacent to the shell did not produce either appetitive eating or defensive treading behaviour.
Alternatively, the glutamate±GABA difference might be explained if accumbens neurons are more potently hyperpolarized by muscimol activation of GABA A receptors on somata and proximal dendrites (Sun & Cassell, 1993; Johnson et al., 1994a) than by blockade of glutamate AMPA/kainate receptors on distal dendritic spines Sesack & Pickel, 1992; Johnson et al., 1994b) . Stronger hyperpolarization of shell neuronal ensembles might conceivably produce sharper motivational valence gradients. If so, it indicates that a single microcircuit might be capable of producing more than one motivational valence, depending on its intensity of hyperpolarization (or duration or constancy of hyperpolarization). The hypothesis that a shell microcircuit may have multiple modes of function is also compatible with many reports that opioid and dopamine agents in accumbens shell have primarily positive motivational effects on behaviour even at caudal shell sites (Bakshi & Kelley, 1993; Pecin Äa & Berridge, 2000; Wyvell & Berridge, 2000; Zhang & Kelley, 2000) . Opioid and dopamine agents would be expected to have complex mixed hyperpolarization and depolarization effects rather than pure hyperpolarization of local microcircuits (Jiang & North, 1992; O'Donnell & Grace, 1995; Hu & White, 1997; Nicola & Malenka, 1997; O'Donnell, 1999) .
The hypothesis that glutamate blockade often produces mixed fear and feeding motivational effects might also help explain why DNQX produces conditioned avoidance even at the most rostral`eating sites' (in addition to causing doubled intensity of conditioned place avoidance at more caudal`fear sites'). It has been suggested that mesolimbic systems, including dopamine projections to accumbens spiny neurons, mediate positive incentive salience but, under some conditions, mediate instead an ambivalent or even negatively valenced fearful salience (Robinson & Berridge, 1993; Berridge & Robinson, 1998; Gray et al., 1999; Berridge, 2001; Kapur, 2003) . If DNQX in rostral shell causes bivalent or ambiguous motivational salience to be assigned to neural representations of external stimuli, partly weighted by rostrocaudal placement, then the motivational valence of a particular stimulus might also partly depend on intrinsic stimulus features and on past experience, as well as on the DNQX microinjection.
For example, food sight and odour may be most likely to be attributed speci®cally with positive incentive salience after rostral or middle shell hyperpolarization, because chow pellets are familiar incentive objects which have often had positive hedonic impact in the past. Even if rostral shell DNQX does not elicit all the features of hunger, as seems true for rostral shell GABA (Maldonado-Irizarry et al., 1995; Reynolds & Berridge, 2002) , shell activation of positive or mixed motivational salience attributed to perceived food could cause eating behaviour. However, a novel place context (such as a place-conditioning apparatus) lacks the positive bias of food stimuli, and may even have slight negative bias for a neophobic rat. Modulation of behavioural fear±feeding valence by stimulus type would occur even more for glutamate blockade than for GABA microinjection, if DNQX elicits motivational salience which is more mixed in positive±negative valence. Thus a novel place may be more likely to be interpreted fearfully when attributed with the same mixture of motivational salience, producing conditioned place avoidance. Such¯exibility in accumbens shell ensembles may hold adaptive value by allowing factors such as environment or past experience to in¯uence motivated behaviour.
Clinical implications
Drugs of abuse such as phencyclidine and other glutamate antagonists can cause paranoid psychotic symptoms in human drug users which, it has been suggested, mimic schizophrenia better than either amphetamine or LSD (Cohen et al., 1966; Javitt & Zukin, 1991; Jentsch & Roth, 1999; Sawa & Snyder, 2002) . Phencyclidine is an NMDA antagonist, but repeated administration also suppresses accumbens AMPA receptor binding (Ellison et al., 1999) . Repeated use of some nonglutamatergic drugs that also cause paranoid psychotic symptoms, such as cocaine (Bartlett et al., 1997) , similarly suppresses the ratio of AMPA : NMDA receptor-mediated postsynaptic currents in accumbens shell and ampli®es dopamine-induced inhibition of AMPA-mediated synaptic responses (Thomas et al., 2001; Beurrier & Malenka, 2002) .
It has been suggested that human schizophrenia involves reduced glutamatergic input to the ventral striatum (Bachus & Kleinman, 1996; Csernansky & Bardgett, 1998) . Decreased levels of accumbens glutamate uptake sites and of AMPA, but not NMDA, receptor binding have been reported in schizophrenics (Aparicio-Legarza et al., 1997; Noga & Wang, 2002) . As an explanatory hypothesis for the positive motivational symptoms of schizophrenia, Kapur recently suggested that elevated mesocorticolimbic function causes excessive incentive salience to be attributed to otherwise innocuous stimuli and events, so that those stimuli or events become perceived as excessively meaningful by psychotic individuals (Kapur, 2003) . While acknowledging the gap between human psychopathology and animal affective neuroscience studies, our results support the idea that mesocorticolimbic dysfunction can cause abnormal motivational salience to be assigned to stimuli, resulting in excessive fascination or fear. Though purely speculative, extrapolation from our results suggests that caudal shell hyperpolarization might produce fearful psychosis symptoms in humans, whereas broader hyperpolarization of both rostral and caudal shell might produce symptoms involving both paranoia and excessive positive incentive motivation too. Aversive and defensive aspects of paranoid psychoses seem especially consistent with the possibility of suppressed AMPA signals in human caudal accumbens shell, which might cause excessive negative motivational salience in schizophrenia (Kapur, 2003) .
Conclusions
These results support suggestions that multiple functional ensembles exist in the nucleus accumbens, modulated by differential glutamate neurotransmission . When hyperpolarized by blockade of excitatory AMPA/kainate signals, rostral and caudal shell microcircuits generate motivated behaviour of opposite motivational valence. Such bivalent gradients indicate that glutamatergic mesocorticolimbic circuits may map appetitive and aversive channels of information via segregated rostrocaudal microcircuits in the medial shell.
